1 completed, 1 not yet recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Pediatric AML: new trials by email Literature Review of Pediatric AML trials Research Report on Pediatric AML
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia sonrotoclax, Azacitidine, Inotuzumab ozogamicin - Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 / Phase 2 | Not yet recruiting | BeOne Medicines | 30 | 2026-12-01 | 2026-10-26 |
| A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) PEG- BCT-100 - Cancer, Pediatric Solid Tumor | Phase 1 / Phase 2 | Completed | University of Birmingham | 49 | 2018-08-28 | 2022-09-02 |
Neoplasms (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Burkitt Lymphoma (1) · Leukemia, Myeloid, Acute (1) · Recurrence (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · DNA Virus Infections (1) · Disease Attributes (1) · Epstein-Barr Virus Infections (1) · Herpesviridae Infections (1) · Infections (1) · Leukemia, Myeloid (1)
Azacitidine (1) · BCT-100 (1) · Dexamethasone (1) · Inotuzumab Ozogamicin (1)
BeOne Medicines (1) · University of Birmingham (1)
Australia (1) · Netherlands (1) · United Kingdom (1)